Evidence map›Paper›PMID 7969143›Full record

ArticleMolecular and cellular biology1994

AML1 is expressed in skeletal muscle and is regulated by innervation.

X Zhu, J E Yeadon, S J Burden

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

X ZhuBiology Department, Massachusetts Institute of Technology, Cambridge 02139.
J E Yeadon
S J Burden
Massachusetts Institute of Technology · US

Funding

REGULATION OF ACHR GENE EXPRESSION--ELECTRICAL ACTIVITYR01NS027963 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BURDEN, STEVEN · 1990 to 2004
$2.1M
NINDS NIH HHS NS27963
6 · The paper itself

Abstract

Although most skeletal muscle genes are expressed at similar levels in electrically active, innervated muscle and in electrically inactive, denervated muscle, a small number of genes, including those encoding the acetylcholine receptor, N-CAM, and myogenin, are expressed at significantly higher levels in denervated than in innervated muscle. The mechanisms that mediate electrical activity-dependent gene regulation are not understood, but these mechanisms are likely to be responsible, at least in part, for the changes in muscle structure and function that accompany a decrease in myofiber electrical activity. To understand how muscle activity regulates muscle structure and function, we used a subtractive-hybridization and cloning strategy to identify and isolate genes that are expressed preferentially in innervated or denervated muscle. One of the genes which we found to be regulated by electrical activity is the recently discovered acute myeloid leukemia 1 (AML1) gene. Disruption and translocation of the human AML1 gene are responsible for a form of acute myeloid leukemia. AML1 is a DNA-binding protein, but its normal function is not known and its expression and regulation in skeletal muscle were not previously appreciated. Because of its potential role as a transcriptional mediator of electrical activity, we characterized expression of the AML1 gene in innervated, denervated, and developing skeletal muscle. We show that AML1 is expressed at low levels in innervated skeletal muscle and at 50- to 100-fold-higher levels in denervated muscle. Four AML1 transcripts are expressed in denervated muscle, and the abundance of each transcript increases after denervation. We transfected C2 muscle cells with an expression vector encoding AML1, tagged with an epitope from hemagglutinin, and we show that AML1 is a nuclear protein in muscle. AML1 dimerizes with core-binding factor beta (CBF beta), and we show that CGF beta is expressed at high levels in both innervated and denervated skeletal muscle. PEBP2 alpha, which is structurally related to AML1 and which also dimerizes with CBF beta, is expressed at low levels in skeletal muscle and is up-regulated only weakly by denervation. These results are consistent with the idea that AML1 may have a role in regulating gene expression in skeletal muscle.

Indexed as

Proto-Oncogene ProteinsAnimalsBase SequenceCloning, MolecularCore Binding Factor Alpha 1 SubunitCore Binding Factor Alpha 2 SubunitCore Binding Factor alpha SubunitsCore Binding FactorsDNA-Binding ProteinsGene ExpressionHumansMolecular Sequence DataMuscle DenervationMuscle ProteinsMusclesNeoplasm ProteinsCore Binding Factor Alpha 1 SubunitCore Binding Factor Alpha 2 SubunitCore Binding Factor alpha SubunitsCore Binding FactorsDNA-Binding ProteinsMuscle ProteinsNeoplasm ProteinsNuclear ProteinsProto-Oncogene ProteinsReceptors, NicotinicRNA, MessengerRUNX1 protein, humanRunx1 protein, ratRUNX2 protein, humanRunx2 protein, ratTranscription Factor AP-2Transcription Factors

Identifiers

PMID7969143
PMCPMC359343
OpenAlexW2164198236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.